Having shown that BCL-XL is a critical anti-apoptotic protein in protecting medulloblastoma cells from apoptosis upon treatment, we were interested in investigating why BCL-XL targeting alone failed to elicit apoptosis. Here, BCL2L1 is linked to medulloblastoma.